Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice
Open Access
- 1 June 2008
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 16 (6), 1120-1128
- https://doi.org/10.1038/mt.2008.81
Abstract
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection in infants, young children, and high-risk adults. Currently, there is no vaccine to prevent RSV infection, and the available therapeutic agents are of limited utility. Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) are a class of antisense agents that can enter cells readily and interfere with viral protein expression through steric blocking of complementary RNA. Two antisense PPMOs, designed to target sequence that includes the 5′-terminal region and translation start-site region of RSV L mRNA, were tested for anti-RSV activity in cultures of two human-airway cell lines. Both PPMOs showed minimal cytotoxicity and one of them, (AUG-2), reduced viral titers by >2.0 log10. Intranasal (i.n.) treatment of BALB/c mice with AUG-2 PPMO before the RSV inoculation produced a reduction in viral titer of 1.2 log10 in lung tissue at day 5 postinfection (p.i.), and attenuated pulmonary inflammation at day 7 postinfection. These data show that the AUG-2 PPMO possesses potent anti-RSV activity and is worthy of further investigation as a candidate for potential therapeutic application.This publication has 52 references indexed in Scilit:
- Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino OligomersJournal of Virology, 2007
- In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile VirusAntimicrobial Agents and Chemotherapy, 2007
- Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection ModelsJournal of Virology, 2007
- Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry SiteJournal of Virology, 2006
- Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino OligomersAntimicrobial Agents and Chemotherapy, 2006
- Activity and Regulation of Alpha Interferon in Respiratory Syncytial Virus and Human Metapneumovirus Experimental InfectionsJournal of Virology, 2005
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in InfancyThe Journal of Infectious Diseases, 2000
- Cost of ribavirin therapy for respiratory syncytial virus infectionThe Journal of Pediatrics, 1995